Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17.66 | 1 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $17.66 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $17.66 | 1 | Lilly USA, LLC ($17.66) |
All Payment Transactions
1 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 459 | 522 | $84,832 | $31,638 |
| 2022 | 11 | 643 | 716 | $122,896 | $51,548 |
| 2021 | 5 | 343 | 368 | $43,203 | $22,013 |
| 2020 | 3 | 75 | 87 | $14,541 | $3,285 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 254 | $40,351 | $18,113 | 44.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 128 | 128 | $33,774 | $10,853 | 32.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 20 | 20 | $2,000 | $811.00 | 40.6% |
| 76000 | Imaging guidance for procedure, 60 minutes or less | Office | 2023 | 23 | 23 | $4,071 | $600.18 | 14.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 32 | $1,280 | $519.04 | 40.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 11 | $1,100 | $380.82 | 34.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 18 | $702.00 | $148.31 | 21.1% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 13 | 13 | $1,209 | $133.54 | 11.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 23 | $345.00 | $78.43 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 227 | 291 | $46,269 | $22,676 | 49.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 183 | 183 | $48,495 | $17,532 | 36.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 63 | 65 | $6,500 | $2,755 | 42.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $4,802 | $2,546 | 53.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $2,899 | $1,975 | 68.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 35 | 35 | $6,195 | $1,550 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 40 | $4,200 | $1,543 | 36.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 17 | 17 | $1,700 | $696.04 | 40.9% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 12 | 12 | $1,116 | $134.11 | 12.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 29 | 31 | $465.00 | $106.68 | 22.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 15 | $255.00 | $33.23 | 13.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 128 | 148 | $15,559 | $9,681 | 62.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 102 | 102 | $18,054 | $8,265 | 45.8% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 44 | 44 | $4,400 | $1,990 | 45.2% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 46 | 48 | $4,800 | $1,986 | 41.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 23 | 26 | $390.00 | $90.48 | 23.2% |
About James Aemisegger, ARNP
James Aemisegger, ARNP is a Emergency healthcare provider based in Inverness, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2013. The National Provider Identifier (NPI) number assigned to this provider is 1699117903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Aemisegger, ARNP has received a total of $17.66 in payments from pharmaceutical and medical device companies, with $17.66 received in 2022. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Food and Beverage" ($17.66).
As a Medicare-enrolled provider, Aemisegger has provided services to 1,520 Medicare beneficiaries, totaling 1,693 services with total Medicare billing of $108,482. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Emergency
- Other Specialties Nurse Practitioner
- Location Inverness, FL
- Active Since 07/28/2013
- Last Updated 07/21/2022
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1699117903
Products in Payments
- EMGALITY (Drug) $17.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.